my 5445 has been researched along with quinazolines in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beretz, A; Cazenave, JP; Corre, G; Lanza, F; Stierlé, A | 1 |
Fujioka, M; Isaka, N; Ito, M; Miyahara, M; Nakano, T; Nishikawa, M; Shiku, H | 1 |
2 other study(ies) available for my 5445 and quinazolines
Article | Year |
---|---|
Cyclic nucleotide phosphodiesterase inhibitors prevent aggregation of human platelets by raising cyclic AMP and reducing cytoplasmic free calcium mobilization.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Alprostadil; Aminoquinolines; Blood Platelets; Calcium; Cyclic AMP; Cytoplasm; Humans; Isoquinolines; Phthalazines; Platelet Aggregation; Quercetin; Quinazolines; Quinolines; Quinolones; Tetrahydroisoquinolines | 1987 |
Characterization of the isoenzymes of cyclic nucleotide phosphodiesterase in human platelets and the effects of E4021.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Blood Platelets; Cyclic Nucleotide Phosphodiesterases, Type 5; Humans; In Vitro Techniques; Isoenzymes; Molsidomine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Phthalazines; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinazolines; Signal Transduction; Thromboxane A2; Tissue Distribution | 1996 |